Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129725) titled 'A multiple-dose, randomized, multicenter, phase II clinical trial to evaluate the efficacy, safety, and pharmacokinetic characteristics of SR604 Injection in patients with von Willebrand disease' on Aug. 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Soochow University
Condition:
Von Willebrand disease
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2025-12-26
Target Sample Size: Experimental group:24;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=324353
Published by...